InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,361.60
(
0.21%
)
Dow Jones
42,124.65
(
0.00%
)
Brent Oil
74.86
(
1.52%
)
Bitcoin
63,495.29
(
0.27%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

buckiii2

Send PM Follow Ignore
Followers 59
Posts 4696
Boards Moderated 0
Alias Born 04/27/2009

buckiii2

Re: None

Thursday, 07/31/2014 7:29:06 AM

Thursday, July 31, 2014 7:29:06 AM

Post# of 23979
SYN.News Release Issued: Jul 31, 2014 (6:57am EDT)
To view this release online and get more information about Synthetic Biologics visit: http://www.syntheticbiologics.com/index.php?s=43&item=187

Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics' Trimesta™ in Multiple Sclerosis to be Presented at 2014 Joint ACTRIMS-ECTRIMS Meeting

-- Oral Presentation to Include Greater Detail on Clinical Outcomes, Including Significant and Unique Improvements in Cognition --September 2014.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up